Therapeutic Utility of Taila Kalpana as External Application – A Review

Abstract

Sneha Kalpana is a fundamental Ayurvedic pharmaceutical process where fats act as carriers of medicinal properties, primarily in the form of taila (oil-based) and ghrita (ghee-based) formulations. Taila preparation involves combining herbal decoctions (kashaya) and pastes (kalka) with oil in precise ratios, preceded by taila murchana to purify and enhance potency. Classical texts describe several preparation methods (paka vidhi), including Agni paka (controlled heating), Aaditya paka (solar exposure), the patana method (using a patana yantra), and the bhavana method (trituration). Each technique ensures proper infusion of therapeutic properties, with unique advantages for preserving volatile compounds, enhancing absorption, or tailoring formulations for specific conditions. Numerous medicated oils are documented for external application in therapies such as abhyanga, pichu, parisheka, and lepa. These formulations address conditions like pidaka, vyanga, vatarakta, kusta, visarpa, and vrana, offering anti-inflammatory, analgesic, and rejuvenating effects. Their lipophilic nature facilitates skin permeation, enabling localized, deep tissue, or systemic actions depending on formulation and application. Prolonged contact time and massage further enhance absorption and circulation, making Taila suitable for chronic disorders, elderly care, and preventive wellness. Modern perspectives highlight parallels between Ayurvedic Taila and topical or transdermal drug delivery systems. Factors such as skin thickness, lipid content, hydration, blood flow, molecular weight, ionization, and partition coefficient influence absorption. Taila’s traditional preparation methods align with these principles, reflecting Ayurveda’s sophisticated understanding of drug delivery through the skin. Bridging traditional wisdom with modern research and standardization is essential to validate efficacy and integrate Taila into evidence-based healthcare.

Keywords

Introduction

Drug delivery system through skin ¹⁸:

Topical and transdermal pharmaceutical products are designed for external application on the skin, with actions varying by depth of penetration. Some act locally on the surface layer, such as keratinolytic agents like salicylic acid. Others penetrate deeper into the dermis or subcutaneous tissue, exemplified by anti-inflammatory gels like diclofenac. Certain formulations achieve systemic absorption, where drugs enter the bloodstream through the skin, as seen in transdermal patches delivering nicotine. This layered approach allows targeted therapy ranging from local to systemic effects.

Transdermal permeation is the process by which a drug applied on the skin surface, usually through a patch or gel, passes through the stratum corneum and moves across deeper layers like the epidermis and dermis. Eventually, it enters capillaries to reach systemic circulation, producing a systemic therapeutic effect.

This permeation occurs through three main pathways. The paracellular route allows small, uncharged molecules to pass between cells. The appendageal route utilizes hair follicles and glands, suitable for larger molecules and ions. The transcellular route involves movement directly through cells, requiring both lipid and water solubility for effective passage.

Factors affecting skin absorption ¹⁹:

1. Physiological factors: drug absorption through the skin is influenced by several physiological and environmental factors. Increased skin thickness decreases absorption since thicker layers act as stronger barriers, while higher lipid content enhances permeability for lipophilic drugs. Greater sweat gland density and hydration improve diffusion, and changes in pH can variably affect absorption depending on the drug’s ionization state. Additionally, increased blood flow promotes systemic uptake, while skin diseases such as dermatitis may either disrupt the barrier or heighten absorption due to inflammation. Elevated temperature further enhances diffusion and circulation, collectively shaping the effectiveness of transdermal and topical drug delivery.

2. Physicochemical factors: drug absorption through the skin is strongly influenced by physicochemical properties of the drug and formulation. Larger molecules with molecular weight above 400 Daltons penetrate less easily, while a higher partition coefficient improves lipid solubility and enhances permeation. Ionized drugs cross membranes less efficiently but longer contact time with the skin increases absorption.

Other factors include the drug affinity to its vehicle—strong binding reduces release to the skin—and particle size, where smaller particles penetrate more effectively. Together, these parameters determine the efficiency of topical and transdermal drug delivery systems.

DISCUSSION:

Taila is a highly adaptable ayurvedic dosage form, widely used in therapies such as abhyanga, pichu, parisheka, and lepa. Its lipophilic nature allows it to permeate the skin effectively, producing both localized and systemic effects. Depending on the formulation and method of application, it can act on different layers of the skin, offering anti-inflammatory, analgesic, and rejuvenating benefits. Prolonged contact time, especially when combined with massage, enhances absorption, circulation, and overall therapeutic efficacy, making taila gentle and suitable for chronic conditions, elderly care, and preventive wellness.

Classical ayurvedic texts describe numerous taila formulations for external use in various diseases, highlighting its therapeutic versatility. The preparation method, known as paka vidhi, plays a crucial role in determining the route of administration—whether external, internal, or nasal—and ensuring suitability for specific conditions. The type of paka depends on the intended use and desired depth of action, reflecting ayurveda’s precision in formulation design.

While traditional wisdom provides a rich foundation, modern science emphasizes the importance of standardization and clinical validation to establish efficacy across diverse clinical contexts. Bridging this gap through research strengthens the credibility of ayurvedic practices and integrates them into evidence-based healthcare. Taila thus represents a unique synergy of traditional knowledge and modern pharmacological potential, offering therapeutic versatility and cultural resonance in holistic medicine.

CONCLUSION:

Many formulations described in the Ayurvedic Formulary of India (AFI) for exclusive external application remain underutilized in the contemporary healthcare market due to limited availability, lack of standardized protocols, and insufficient clinical validation. To ensure their wider acceptance and therapeutic credibility, these preparations demand rigorous pharmaceutical standardization, analytical validation, and well?designed clinical studies that can generate reproducible evidence. Modern scientific exploration is particularly necessary to establish how traditional dosage forms such as taila offer unique benefits in external applications, including enhanced penetration, sustained therapeutic action, and compatibility with diverse skin conditions. Bridging classical wisdom with modern research methodologies will not only strengthen the evidence base but also facilitate integration of these formulations into mainstream practice. Thus, systematic validation and evidence?based documentation are essential to unlock the full potential of AFI?listed external formulations and reaffirm the relevance of taila in contemporary therapeutics.

REFERENCES

1. Kadibagil VK, Sukumar BS. Textbook of Rasashastra evam Bhaishajya Kalpana. 1st ed. Varanasi: Chaukhambha Publication; 2024. Vol. 1. Chapter Kalpana Nirmana. P.133
2. Kadibagil VK, Sukumar BS. Textbook of Rasashastra evam Bhaishajya Kalpana. 1st ed. Varanasi: Chaukhambha Publication; 2024. Vol. 1. Chapter Kalpana Nirmana. P.131
3. Government of India, Ministry of Health and Family Welfare, Department of Indian Systems of Medicine & Homoeopathy. The Ayurvedic Formulary of India. Part III. New Delhi: Controller of Publications; 2003.
4. Government of India, Ministry of Health and Family Welfare, Department of Indian Systems of Medicine & Homoeopathy. The Ayurvedic Formulary of India. Part I. New Delhi: Controller of Publications; 2003.
5. Government of India, Ministry of Health and Family Welfare, Department of Indian Systems of Medicine & Homoeopathy. The Ayurvedic Formulary of India. Part II. New Delhi: Controller of Publications; 2003.
6. PV Sharma, chakradutta (Sanskrit text with english translation) 2007 edition. Chaukhambha Orientalia, Varanasi ch-50/157. P-408.
7. Pagad, A., Mishra, A. K., & Hussain, G. (2023). Comparative analytical evaluation of Pruthvisara taila prepared by two different methods. International Journal of Ayurvedic Medicine, 14(3), 789–793. https://doi.org/10.47552/ijam.v14i3.3856.
8. Shah CN.Bharath Bhaishajya Ratnakara.Reprint ed.New Delhi.B.Jain publishers ltd; 1999. Vol. 2, P. 60.
9. Shah CN.Bharath Bhaishajya Ratnakara.Reprint ed.New Delhi.B.Jain publishers ltd; 1999. Vol. 4, P.683.
10. Shah CN.Bharath Bhaishajya Ratnakara.Reprint ed.New Delhi.B.Jain publishers ltd; 1999. Vol. 4, P.97.
11. Sachin S. Sheth, Gangaprasad R. Asore, Pooja A. Tambe. Preparation of Gandhak Taila by Patalyantra    method    and    Pharmaceutico-analytical Study of  Gandhak  Taila cream. J Ayurveda  Integr  Med Sci 2022; 3:41-46. http://dx.doi.org/10.21760/jaims.7.3.6.
12. Gangaprasad R. Asore, Sachin S. Sheth, Prajakta D. Pansare, Preparation of Visarpahar Taila by Patalyantra Method and Pharmaceutico-Analytical Study of Visarpahar Taila Cream. J Ayu Int Med. Sci. 2022;7(2):22-27.
13. Jayashree Ranjani, Reshma M Saokar and Sujatha K. Pharmaceutical study of Eranda Taila extracted from Eranda Beeja with and without shodhana. Int. J. Res. Ayurveda Pharm. 2024;15(4):65-69 DOI: http://dx.doi.org/10.7897/2277-4343.154119.
14. Vagbhata A. Rasa Ratna Sammucchaya. Hindi translation by Mishra S. Varanasi: Chaukhambha Orientalia; 2021. Chapter 20, Shloka 180. p.488
15. Sharma S, Shastri K. Rasa Tarangini. Varanasi: Motilal Banarasidas; 2012 edition. Chapter 8, Astama Taranga, Shloka, 96-98. P.192.
16. Sharma S, Shastri K. Rasa Tarangini. Varanasi: Motilal Banarasidas; 2012 edition. Chapter 8, Astama Taranga, Shloka, 94–95. P.191.
17. Vagbhata A. Rasa Ratna Sammucchaya. Hindi translation by Mishra S. Varanasi: Chaukhambha Orientalia; 2021. Chapter 20, Shloka 181–182. P.488.
18. Andrea Crasta, Tanvi Painginkar, Amatha Sreedevi, Sachin Dattram Pawar, Muddukrishna Badamane Sathyanarayana, S.G. Vasantharaju, Riyaz Ali M. Osmani, Gundawar Ravi, Transdermal drug delivery system: A comprehensive review of innovative strategies, applications, and regulatory perspectives, Open Nano, Volume 24, 2025, 100245, ISSN 2352-9520, https://doi.org/10.1016/j.onano.2025.100245.
19. Vaseem RS, D'cruz A, Shetty S, - H, Vardhan A, R SS, Marques SM, Kumar L, Verma R. Transdermal Drug Delivery Systems: A Focused Review of the Physical Methods of Permeation Enhancement. Adv Pharm Bull. 2024 Mar;14(1):67-85. doi: 10.34172/apb.2024.018. Epub 2023 Oct 14. PMID: 38585458; PMCID: PMC10997930.